Scarica l'app Stockscreener
100.03
1.74%
-1.765
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Another FCA Cybersecurity Settlements Highlight DOJ’s Enforcement Priorities - JD Supra
New Empirical Research Report on Human Microbiome Sequencing - openPR.com
Immune Repertoire Sequencing Market Outlook (2025-2032): - openPR.com
Illumina names Nilesh Shah as head of region, AMEA - Medical Buyer
Risk adjusted return profile for Illumina Inc. analyzedEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Ranking Illumina Inc. among high performing stocks via toolsJuly 2025 Volume & Technical Entry and Exit Tips - Newser
Nilesh Shah joins Illumina as Head of Region, AMEA - BioSpectrum Asia
Using R and stats models for Illumina Inc. forecasting2025 Technical Overview & Growth Focused Stock Reports - Newser
Chart based exit strategy for Illumina Inc.Fed Meeting & Growth Focused Stock Pick Reports - Newser
Will Illumina Inc. stock recover after recent dropChart Signals & High Accuracy Swing Trade Signals - Newser
Real time breakdown of Illumina Inc. stock performanceJobs Report & Momentum Based Trading Signals - Newser
Volatility clustering patterns for Illumina Inc.Bond Market & AI Forecasted Entry and Exit Points - Newser
Applying Elliott Wave Theory to Illumina Inc.Earnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Icahn exits Illumina, Dana; boosts stakes in CVR Energy - MSN
How to monitor Illumina Inc. with trend dashboardsShare Buyback & High Accuracy Trade Alerts - Newser
What to expect from Illumina Inc. in the next 30 daysTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Illumina sets an example in disability inclusion - Illumina
Is Illumina Inc. stock heavily shortedWeekly Investment Summary & Verified Chart Pattern Signals - classian.co.kr
How to manage a losing position in Illumina Inc.July 2025 EndofMonth & Daily Profit Focused Screening - Newser
How to forecast Illumina Inc. trends using time seriesTrade Analysis Report & Fast Momentum Entry Tips - Newser
Best data tools to analyze Illumina Inc. stockQuarterly Trade Report & Growth Focused Entry Reports - Newser
Statistical indicators supporting Illumina Inc.’s strengthMarket Performance Report & Daily Risk Controlled Trade Plans - Newser
Price action breakdown for Illumina Inc.Swing Trade & AI Based Buy/Sell Signal Reports - Newser
The future of precision oncology: Scaling NGS with smarter variant interpretation - Illumina
What candlestick patterns are forming on Illumina Inc.2025 Market Outlook & Community Verified Trade Alerts - Newser
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina - ADVFN Brasil
Is Illumina Inc. on track to beat earningsJuly 2025 Summary & High Accuracy Swing Entry Alerts - newsyoung.net
Carl Icahn raises shared share stake in Centuri Holdings, dissolves in Dana, Illumina - MarketScreener
Carl Icahn Exits Dana, Illumina, Increases CVR Energy Stake in Q2 - AInvest
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Now that NGS is more affordable, how can we make it easier? - Illumina
Illumina shares rise 1.18% premarket after Daiwa Securities downgrades to Neutral from Outperform. - AInvest
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Illumina (NASDAQ:ILMN) Downgraded by Daiwa Capital Markets to Neutral - Defense World
Illumina Settles $9.8M False Claims Case Over Vulnerable Genomic Systems - WebProNews
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - TradingView
Illumina Downgraded to Neutral by Daiwa Securities - AInvest
Illumina Sees Future Rebound in China Sales - San Diego Business Journal
Daiwa Securities Downgrades Illumina to Neutral From Outperform, Adjusts Price Target to $94 From $124 - MarketScreener
US Personalized Medicine Market Trends and Company Analysis - GlobeNewswire
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
How Illumina Inc. stock performs during market volatilityMaximum Yield Stock Screener - classian.co.kr
Standard BioTools Announces SomaLogic Sale to Illumina - TipRanks
Latest Cybersecurity False Claims Act Settlement with Diagnostics Provider Focuses on Sensitive Health Systems - Inside Privacy
Illumina price leans on SMA supportForecast today11-08-2025 - Economies.com
DNA Microarray Market to Grow at 9% CAGR, Driven by Personalized - openPR.com
Single Cell Genome Sequencing Market is evolving rapidly Through 2025 To 2032 | Illumina, Inc., Fludigim Corporation - openPR.com
What MACD and RSI say about Illumina Inc.Daily Swing Candidate Analysis with Chart Patterns - Newser
Is Illumina Inc. a strong growth stockEarnings Surprise Driven Picks - thegnnews.com
What makes Illumina Inc. stock price move sharplyMulti-Sector Diversified Watchlist - thegnnews.com
What are analysts’ price targets for Illumina Inc.Weekly Oversold Bounce Candidates - thegnnews.com
DOJ Settlement With Medical Technology Company Signals Expanding Cybersecurity FCA Risk for Life Sciences Companies - JD Supra
Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues - simplywall.st
An introduction to the Illumina 5-Base Solution - Illumina
Detecting price anomalies in Illumina Inc. with AIShort-Term Swing Opportunity Summary Sheet - Newser
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Settles With DOJ, Veterans to End Whistleblower Lawsuit Over Genomic Sequencing Systems with Cybersecurity Vulnerabilities - AInvest
1.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):